Axon Enterprise’s (AXON) Outperform Rating Reaffirmed at William Blair

William Blair reaffirmed their outperform rating on shares of Axon Enterprise (NASDAQ:AXON) in a research report report published on Wednesday morning, RTT News reports.

A number of other research firms have also commented on AXON. JPMorgan Chase & Co. raised their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an overweight rating in a research report on Thursday, April 11th. Needham & Company LLC restated a buy rating and issued a $400.00 price objective on shares of Axon Enterprise in a research report on Wednesday. Barclays raised their price objective on shares of Axon Enterprise from $296.00 to $308.00 and gave the company an overweight rating in a research report on Thursday, February 29th. JMP Securities raised their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a market outperform rating in a research report on Tuesday, February 6th. Finally, Morgan Stanley raised their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the company an equal weight rating in a research report on Wednesday, February 28th. Two analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of Moderate Buy and an average price target of $314.91.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $308.23 on Wednesday. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $23.26 billion, a PE ratio of 134.01 and a beta of 0.93. Axon Enterprise has a twelve month low of $175.37 and a twelve month high of $329.87. The company has a 50-day moving average price of $303.45 and a two-hundred day moving average price of $260.90.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm had revenue of $432.14 million during the quarter, compared to analyst estimates of $418.97 million. Equities analysts forecast that Axon Enterprise will post 2.44 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. ICA Group Wealth Management LLC purchased a new position in shares of Axon Enterprise during the fourth quarter worth approximately $26,000. Trivant Custom Portfolio Group LLC purchased a new position in shares of Axon Enterprise during the first quarter worth approximately $31,000. BKM Wealth Management LLC purchased a new position in shares of Axon Enterprise during the fourth quarter worth approximately $32,000. First PREMIER Bank purchased a new position in shares of Axon Enterprise during the first quarter worth approximately $33,000. Finally, Key Financial Inc raised its stake in shares of Axon Enterprise by 367.6% during the fourth quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after acquiring an additional 125 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.